REGISTRATION NOW CLOSED
This meeting is supported by:
PROGRAMME
| 09.00 - 09.55 | Arrival, registration and coffee |
| 09.55 - 10.00 | Welcome and introduction Sam Butterworth, University of Manchester |
|
Session 1 Chair: Phil Jeffrey, Bicycle Therapeutics |
|
| 10.00 - 10.40 | 1-1 Evolution of DMPK in last 25 years and
emerging challenges
Scott Summerfield, Pharmaron |
| 10.40 - 11.20 | 1-2 Modelling clinical PK in disease populations
Dan Scotcher, Centre for Applied Pharmacokinetic Research, University of Manchester |
| 11.20 - 12.00 | 1-3 The prediction of human pharmacokinetics in early-stage drug discovery
Simon Thomas, Cyprotex/Evotec |
| 12.00 - 13.00 | Lunch break |
|
Session 2 Chair: Mo Alavijeh, Pharmidex |
|
| 13.00 - 13.40 | 2-1 Multi-organ microphysiological systems: a promising tool for more predictive studies of human drug ADME and oral bioavailability
Tomasz Kostrzewski, CN-Bio |
| 13.40 - 14.20 | 2-2 Current and future analytical challenges and opportunities for DMPK
Mohammed Abrar, BioApp Solutions |
| 14.20 - 15.00 | 2-3 Predicting Routes of Phase I and II Metabolism based on Quantum Mechanics and Machine Learning
Matt Segall, Optibrium |
| 15.00 - 15.20 | Coffee break
|
|
Session 3 Chair: Sam Butterworth, University of Manchester |
|
| 15.20 - 16.00 | Priorities and opportunities for advances in DMPK in the next 10 years -
Roundtable discussion All |
| 16.00 | Closing remarks and meeting ends Sam Butterworth, University of Manchester |